Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahjoubi

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Investigational New Drugs|November 1, 1993
Phase II trial of LY 186641 in advanced renal cancerM Mahjoubi, J Kattan, M Bonnay, et al.
Cancer Investigation|January 1, 1990
Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancerM Mahjoubi, M Azab, M Ghosn, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in miceS Guichard, E Chatelut, I Lochon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Preoperative chemotherapy of locally advanced gastric cancerP Rougier, P Lasser, M Ducreux, et al.
Investigational New Drugs|November 1, 1992
Phase II trial of pirarubicin in the treatment of advanced bladder cancerM Mahjoubi, J Kattan, M Ghosn, et al.
Cancer Investigation|January 1, 1994
Phase II trial of pirarubicin in the treatment of advanced pancreatic cancerM Mahjoubi, P Rougier, J Oliviera, et al.
Bulletin Du Cancer|January 1, 1992
[Brain metastasis of choriocarcinoma in males. Apropos of a case. Review of the literature]C Soussain, P Michel-Langlet, M Mahjoubi, et al.
American Journal of Clinical Oncology|June 1, 1994
Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion scheduleJ Kattan, M Durand, J P Droz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumoursJ Kattan, M Mahjoubi, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reportsE Wasserman, A Myara, F Lokiec, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Investigational New Drugs|November 1, 1993
Phase II trial of LY 186641 in advanced renal cancerM Mahjoubi, J Kattan, M Bonnay, et al.
Cancer Investigation|January 1, 1990
Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancerM Mahjoubi, M Azab, M Ghosn, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in miceS Guichard, E Chatelut, I Lochon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Preoperative chemotherapy of locally advanced gastric cancerP Rougier, P Lasser, M Ducreux, et al.
Investigational New Drugs|November 1, 1992
Phase II trial of pirarubicin in the treatment of advanced bladder cancerM Mahjoubi, J Kattan, M Ghosn, et al.
Cancer Investigation|January 1, 1994
Phase II trial of pirarubicin in the treatment of advanced pancreatic cancerM Mahjoubi, P Rougier, J Oliviera, et al.
Bulletin Du Cancer|January 1, 1992
[Brain metastasis of choriocarcinoma in males. Apropos of a case. Review of the literature]C Soussain, P Michel-Langlet, M Mahjoubi, et al.
American Journal of Clinical Oncology|June 1, 1994
Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion scheduleJ Kattan, M Durand, J P Droz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumoursJ Kattan, M Mahjoubi, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reportsE Wasserman, A Myara, F Lokiec, et al.
Pageof 3